Categories
Archives
- 2026
- 2025
- 2024
- 2023
Sep
30
Inside a PowerHouSe: Conversations, Connection & Learning at the 2026 UCB HS Summit
Sep
29
UCB data presented at 2026 AANEM Annual Meeting and MGFA Scientific Session underscore leadership in advancing targeted treatments for gMG
Sep
09
UCB receives U.S. FDA Breakthrough Therapy Designation for CIMZIA® (certolizumab pegol) in pregnant women with antiphospholipid syndrome (APS)
Aug
31
UCB Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S. Manufacturing
Aug
16
Axios Names UCB a Winner of the Metro Atlanta Top Workplaces 2026 Award
Aug
05
Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients with Lennox-Gastaut syndrome
Jul
07
UCB Awards Annual Myasthenia Gravis Scholarships to 15 Individuals Impacted by MG in the U.S.
Jun
17
UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI® (doxecitine and doxribtimine) in Patients with Thymidine Kinase 2 Deficiency (TK2d)
Jun
04
Supporting Families During Dravet Syndrome Awareness Month: A look into Camp Small Steps
